The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Egalet Announces Issuance of New US Patent for Guardian™ Technology

05-Jun-2017 | Source : Egalet Corporation | Visits : 4678
WAYNE, Pa. - Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, announced in a press release it has received a US patent for its proprietary Guardian™ Technology tablet architecture used to create precise delivery of combination products with immediate-, delayed- and/or extended-release properties.

"The newly issued patent adds to the flexibility for what we can do with future products and partnerships using our Guardian Technology," said Bob Radie, president and chief executive officer of Egalet. "This technology puts us at an advantage to create more sophisticated delivery systems for many different kinds of pharmaceutical products."
The patent covers Guardian's robust technology used to create immediate-, delayed- and/or extended-release tablets with precise drug delivery of one or two different active pharmaceutical ingredients.

The United States Patent and Trademark Office (USPTO) has issued patent number 9,642,809 covering Guardian Technology. The patent offers protection through June 4, 2028.

Egalet has been granted a total of 19 US patents and 94 patents outside of the US that cover Guardian Technology and its product candidates.

Related Articles